Marie Antoinette’s quote is a great reminder that at times, new uses can be found with old things, such is the case with the drug Naltrexone. First synthesized as a competitive opioid antagonist in 1963, for many years research on Naltrexone remained dormant until
Xenoestrogens is a word I recently discovered in my health-related reading, and I had no idea what they were. It sounds very technical and scary, and I wasn’t sure I wanted to even dive into the research to figure out what these things are. But, I did, and it is...
More than half of all people with thyroid disease are unaware of their condition. Many patients have tried synthetic thyroid hormones, such as levothyroxine and liothyronine, and have found that Natural Thyroid is the only form that works adequately for them, reporting that they simply do not feel as well when they take levothyroxine alone or with liothyronine. Currently, certain forms and strengths of Natural Thyroid are available only through compounding pharmacies.
Coming up with new drug delivery techniques that can precisely target cancer cells, while leaving healthy tissue unharmed, has been a major goal for cancer researchers in recent years. Scientists at the University of Manchester have been testing a new approach that relies on liposomes. The new studies demonstrate for the first time how they can be built to include a temperature control, which could be an effective way of targeting treatment towards cancer cells while leaving healthy cells unharmed.
The world is facing the threat of ‘superbugs’ as these bacteria dubbed as methicillin-resistant Staphylococcus aureus (MRSA) have evolved into one of the most difficult-to-treat pathogens. MRSA is a bacteria that is resistant to many antibiotics. In the external community, most MRSA infections are skin infections. In medical facilities, MRSA causes life-threatening bloodstream infections, pneumonia and surgical site infections. A new study suggests that treatment with the wrong antibiotic could make MRSA-induced infections worse.
Researchers reported the first evidence that a new class of drugs known to dramatically lower cholesterol may also reduce risk of heart attacks, strokes and other serious consequences of cardiovascular disease. The drugs represent the most important new class of cholesterol-lowering medications since the first statin was approved in 1987.
We use cookies to optimize our website and our service.
Functional cookies Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.